China NMPA Product Recall - Intramedullary nail system

The National Medical Products Administration (NMPA) issued a voluntary recall notice on April 13, 2016, concerning an intramedullary nail system manufactured by Synthes GmbH. This recall was reported by Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. on March 26, 2016. The primary issue identified was improper etching, which led to certain intramedullary nails (models 473.385 and 473.585) being incorrectly bent for the opposite side (e.g., a left-side nail bent as a right-side nail) despite unilateral etching. This manufacturing defect posed significant risks, potentially causing surgical delays if detected during an operation. More critically, if the incorrect bending went unnoticed and the surgeon attempted insertion, it could result in severe complications, including an intraoperative fracture. This recall falls under the regulatory framework of the NMPA (formerly CFDA), specifically concerning products registered under certificate number CFDA (Imported) No. 20143464093. Despite the recall, Johnson & Johnson confirmed that none of the affected product batches (including 2226946, 2282830, and 2226945) were imported into or sold within the Chinese market. Consequently, no direct corrective actions were mandated for products within China. However, provincial NMPA branches were advised to strengthen supervision and management of similar medical devices to uphold public safety standards.